About GNOMX CORP.
GNOMX Corp. is a company developing a next-generation epigenetic and AI diagnostic platform for infectious diseases. They were awarded a contract by BARDA DRIVe for sepsis patient readmission prediction.
Next-generation epigenetic diagnostic platformAI diagnostic platform for infectious diseasesSepsis patient readmission prediction
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| GNOMX: AREA OF INTEREST NO. 23 HOST-BASED DIAGNOSTICS. THE OVERALL GOAL OF THIS PROJECT IS TO VALIDATE A HOST- | Department of Health and Human Services | $750K |
Teaming History
Prime contractors GNOMX CORP. has worked under:
- Icahn School Of Medicine At Mount Sinai — 1 subcontract(s)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GNOMX CORP. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.